Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekmYCfbwocfbuTqROsqa

February 14, 2013
Sign upForwardArchiveAdvertise
News for nurse practitioners

  Health Care News 
  • High calcium intake may add to women's risk of cardiac death
    Daily dietary intake or supplementation of more than 1,400 milligrams of calcium was linked to an almost twofold increased risk of dying from heart problems, Swedish researchers reported in the journal BMJ. They noted that women whose calcium intake was less than 600 milligrams also appeared to be at increased risk. HealthDay News (2/12) LinkedInFacebookTwitterEmail this Story
  • Study ties healthier lifestyle to lower GDM risk
    About 78% of obese pregnant women who underwent caloric restriction with mild physical activity were able to stay within the acceptable-weight-gain range, compared with 30% of those in the control group, a study found. The lifestyle-change treatment also lowered the risk of gestational diabetes mellitus, hypertension and preterm delivery, according to the study that is to be presented at the annual meeting of the Society for Maternal-Fetal Medicine. Yahoo/Asian News International (2/12) LinkedInFacebookTwitterEmail this Story
  • Neurostimulation may have benefits in early Parkinson's
    Researchers tracked 251 patients with early-stage Parkinson's disease and found that those who received medication plus deep brain stimulation had improved quality of life and mobility compared with those treated with drugs alone. "The data suggest that patients can safely, and with significantly better outcome, receive neurostimulation," said senior author and neurologist Gunther Deuschl. The study appeared in the New England Journal of Medicine. HealthDay News (2/13) LinkedInFacebookTwitterEmail this Story
  • Diabetes patients with, without angina show comparable CVD risks
    Diabetes patients who have stable coronary artery disease with and without angina and other symptoms do not have significant differences in the risk of cardiovascular disease events and death, researchers reported in the Journal of the American College of Cardiology. Data on 2,364 patients showed the cumulative rates of cardiovascular events at five years were 24% in those with angina and 21% in those without symptoms, while the cumulative mortality rates were 12% in patients with angina and 10% in patients without symptoms. Medscape (free registration) (2/12) LinkedInFacebookTwitterEmail this Story
  • Some hormonal contraceptives may raise diabetes risk
    Long-acting reversible contraceptives were associated with an increased risk of type 2 diabetes in obese women, according to a study in the journal Contraception. Data on three types of birth-control methods showed women who had progestin-releasing LARC devices implanted under the skin had a 10% increase in fasting blood glucose levels, compared with a 5% increase in those who used a progestin-releasing IUD and a 2% decrease in those who opted for non-hormonal contraceptives. Toronto Sun/QMI Agency (2/8), NewKerala.com (India)/Asian News International (2/8) LinkedInFacebookTwitterEmail this Story
  • Study: Autism risk may fall with prenatal intake of folic acid
    Taking folic acid supplements before conception and early in pregnancy was associated with a lower risk of having children with autism, according to a Norwegian study in the Journal of the American Medical Association. The effects of folic acid on genes and DNA repair may explain its role in brain development disorders in babies, including autism, researchers said. Reuters (2/12) LinkedInFacebookTwitterEmail this Story
  Pharmaceutical News 
  • FDA updates watch list by adding 3 drugs
    The FDA added GlaxoSmithKline's leukemia drug Arzerra, or ofatumumab; UCB's epilepsy, liver and kidney drug Vimpat, or lacosamide; and Acorda Therapeutics' multiple sclerosis, kidney and liver drug Ampyra, or dalfampridine, to its list of products to monitor due to new safety information or possible signs of serious risks. The FDA received reports of potential adverse events involving the treatments in last year's third quarter. A sunscreen was also added to the list. Medscape (free registration) (2/12) LinkedInFacebookTwitterEmail this Story
  • Analysis: Diclofenac's heart risks warrant caution
    Diclofenac, a nonsteroidal anti-inflammatory drug, was associated with an up to 63% higher risk of cardiovascular events, and should be eliminated from essential-medicines lists, according to a meta-analysis published online in PLoS Medicine. Diclofenac was the most widely used NSAID in 15 countries, and its heart risk was comparable to that of rofecoxib, which was withdrawn from the market due to its cardiovascular toxocicty. TheHeart.org (Montreal) (free registration) (2/13) LinkedInFacebookTwitterEmail this Story
  Emerging Trends, Products and Technologies 
  • Who has health coverage, and who still needs it?
    The Gallup-Healthways Well-Being Index reports that the percentage of young adults in the U.S. who lack insurance continues to fall, while older age groups are holding steady. Most seniors have coverage, and the percentage of overall Americans without insurance is also falling. Hispanic people and those with low incomes are the most likely to be uninsured, followed by young adults, despite the recent gains. Gallup.com (2/11) LinkedInFacebookTwitterEmail this Story
  Health Policy and Legislative News 
  • States prepare to market health coverage to the uninsured
    States faced with the prospect of bringing millions of people into health insurance exchanges are developing strategies such as partnering with local celebrities and athletes to reach the 30 million uninsured Americans who will soon be eligible for coverage under the Affordable Care Act. "We have to look at doing things a lot differently than what's been done in the past because this is a very unique audience, and we're marketing a product that's never been marketed before," said Michael Marchand of the Washington Health Benefit Exchange. The Wall Street Journal (2/12) LinkedInFacebookTwitterEmail this Story
  AANP News 
  • Medication shortages and opioid use
    Urgent Matters, a national initiative funded by the Robert Wood Johnson Foundation, is dedicated to finding, developing and delivering strategies to improve patient flow and reduce emergency department crowding. Urgent Matters highlights patient flow best practices through its educational activities including: e-newsletters, Web seminars and regional conferences. Read the latest on medication shortages and opioid use in the emergency department that have dominated the news media in the past months. This e-newsletter focuses on the impacts medication shortages have on patient safety and how to combat these shortages as well as a program launched to prevent the overprescribing of controlled medications and overuse of the ED. Read more. LinkedInFacebookTwitterEmail this Story
  • Job postings have soared on AANP CareerLink
    We now have over 1,000 available positions on our job board today while averaging 300 new jobs each month. Find your life's calling and explore the career center to see what’s available right now. Registering with AANP CareerLink provides job seekers the perfect place to search relevant positions for their next career move. Find jobs easy and quick without the noise of sifting through irrelevant nursing jobs, visit www.healthecareers.com/aanp today! LinkedInFacebookTwitterEmail this Story
Learn more about AANP ->Home Page | Join AANP | Legislation/Practice | CareerLink

  SmartQuote 
Mistakes are part of the dues that one pays for a full life."
--Sophia Loren,
Italian actress


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AANP SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information